• Resiniferatoxin (RTX): Transforming Analgesia Research in OA

  2026-04-25

  Resiniferatoxin (RTX) stands out as a selective and ultra-potent TRPV1 agonist, delivering unprecedented nerve desensitization and durable pain relief in preclinical and clinical models of osteoarthritis. With precise dosing and robust safety profiles, RTX unlocks advanced workflows for dissecting pain pathways and developing next-generation analgesic agents.

• BH3 Mimetics Target Senescent Cells in TP53 Wild-Type Breast

  2026-04-24

  This study demonstrates that BH3 mimetics, specifically BCL-XL inhibitors, selectively eliminate chemotherapy-induced senescent breast cancer cells in TP53 wild-type settings. The findings highlight a strategy to minimize residual disease and improve outcomes in patient populations that typically show poor chemotherapy responses.

• GPR107 Deficiency Drives Diabetic Nephropathy via AT1R/Ca2+

  2026-04-24

  Xu et al. (2025) reveal that loss of GPR107 in podocytes intensifies diabetic nephropathy by disrupting clathrin-mediated endocytosis of AT1R, thus aberrantly activating calcium signaling and promoting collagen IV accumulation. These results clarify a mechanistic link between impaired endocytosis, Ca2+ signaling, and glomerular damage, suggesting GPR107 as a potential therapeutic target for kidney complications in diabetes.

• SU 5402: Applied Workflows for Cancer Biology & Neuronal Mod

  2026-04-23

  SU 5402 stands out as a versatile inhibitor for dissecting receptor tyrosine kinase signaling in both cancer and neuronal research. This article details experimental workflows, protocol optimizations, and troubleshooting tips that maximize the compound’s value, with insights drawn from validated human iPSC-neuron and oncology models.

• WZ4003: Applied Uses of a Potent NUAK1/2 Inhibitor in Cell a

  2026-04-23

  WZ4003 unlocks precision control over NUAK1/2 signaling, enabling researchers to dissect cell migration, proliferation, and tau phosphorylation with high specificity. This guide covers detailed workflows, assay enhancements, and troubleshooting strategies that maximize reproducibility and insight using APExBIO’s WZ4003.

• Methyl-β-cyclodextrin: Practical Guide for Cholesterol Extra

  2026-04-22

  Methyl-β-cyclodextrin is a high-purity reagent for selective cholesterol and lipid extraction from cell membranes, supporting studies in membrane fluidity and lipid raft dynamics. It is intended for controlled research use and not for diagnostic or medical applications, with strict recommendations on solution freshness and storage. Researchers should follow specified protocol and QC parameters to maximize reproducibility and avoid common pitfalls.

• Advancing In Vitro Drug Response Metrics in Cancer Research

  2026-04-22

  Schwartz's dissertation introduces an innovative framework for distinguishing between proliferative arrest and cell death in cancer drug studies, revealing that most agents—including topoisomerase 1 inhibitors—impact both parameters with distinct kinetics. These insights refine assay interpretation and support more accurate evaluation of antitumor agents in preclinical research.

• DiD (DiDC 18 (5)) for High-Fidelity Plasma Membrane Staining

  2026-04-21

  DiD (DiDC 18 (5)) delivers uniform, robust plasma membrane labeling, ideal for tracking cell migration and neuronal pathways—even in autofluorescent or inflammatory microenvironments. This guide translates recent innovations and practical workflows into actionable protocols, troubleshooting, and advanced use-cases for next-generation cell biology.

• AICAR Phosphate (Acadesine): Optimized Workflows for B-CLL A

  2026-04-21

  AICAR phosphate (Acadesine) from APExBIO enables precise, AMPK-driven apoptosis induction in B-cell chronic lymphocytic leukemia (B-CLL) research, with robust selectivity and mitochondrial pathway engagement. This guide delivers evidence-based protocols, advanced troubleshooting, and practical insights inspired by the latest mechanistic studies.

• Scenario-Driven Best Practices: Dibutyryl-cAMP, Sodium Salt

  2026-04-20

  This article addresses common laboratory challenges in cAMP signaling pathway research, cell viability, and proliferation assays, demonstrating how Dibutyryl-cAMP, sodium salt (SKU B9001) from APExBIO provides reliable, reproducible, and cost-efficient solutions. Drawing on real-world scenarios and literature-backed practices, it guides scientists in optimizing assay design and interpretation using this stable cAMP analog.

• Amiloride (MK-870): ENaC Inhibition and Research Boundaries

  2026-04-20

  Amiloride (MK-870) is a validated epithelial sodium channel (ENaC) inhibitor supplied by APExBIO. It is widely used in sodium channel research and studies on cellular endocytosis modulation. Benchmarks highlight its specificity, storage parameters, and mechanistic limits for ion transport and receptor pathway investigations.

• Notopterol Modulates Macrophage Metabolism via α7nAChR in Sy

  2026-04-19

  This study reveals that Notopterol, a natural compound, attenuates synovitis by reprogramming macrophage metabolism through the α7 nicotinic acetylcholine receptor (α7nAChR). The findings highlight a novel mechanism where metabolic shifts from glycolysis to oxidative phosphorylation promote anti-inflammatory macrophage polarization, offering a promising therapeutic avenue for inflammatory arthritis.

• Metoprolol Tartrate in Cardiovascular and Hematopoietic Rese

  2026-04-18

  Metoprolol Tartrate is the gold standard β1-adrenergic blocking agent for precise cardiovascular and regenerative medicine research, offering unmatched selectivity and versatility. Learn how to optimize protocols, avoid common pitfalls, and leverage the latest insights from hematopoietic regeneration studies for your lab’s success.

• TCAIM Modulates Mitochondrial Metabolism via OGDH Regulation

  2026-04-17

  Wang et al. (2025) identify TCAIM as a DNAJC co-chaperone that selectively binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, unveiling a new post-translational regulatory mechanism in mitochondrial metabolism. These findings have significant implications for understanding metabolic adaptation and proteostasis in mammalian cells.

• Dissecting Drug Responses in Cancer: Insights from In Vitro

  2026-04-16

  Schwartz's dissertation systematically interrogates how in vitro assays measure anti-cancer drug responses, revealing critical distinctions between proliferative arrest and direct cell killing. These findings underscore the need for nuanced assay selection in cancer research and have direct implications for evaluating multi-target drugs such as Pazopanib Hydrochloride.

15462 records 1/1031 page Next 12345 下5页 Last page